关注
Sarath lal K C, S K C
Sarath lal K C, S K C
Research Associate
在 pilani.bits-pilani.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Epigenetics in neurodegenerative diseases: the role of histone deacetylases
S Sharma, KC Sarathlal, R Taliyan
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2019
442019
Exploring the neuroprotective potential of rosiglitazone embedded nanocarrier system on streptozotocin induced mice model of Alzheimer’s disease
S KC, V Kakoty, S Marathe, D Chitkara, R Taliyan
Neurotoxicity research 39, 240-255, 2021
282021
Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
R Taliyan, V Kakoty, KC Sarathlal, SS Kharavtekar, CR Karennanavar, ...
Journal of Controlled Release 343, 528-550, 2022
272022
Therapeutic approaches to Alzheimer’s type of dementia: a focus on FGF21 mediated neuroprotection
R Taliyan, SK Chandran, V Kakoty
Current Pharmaceutical Design 25 (23), 2555-2568, 2019
252019
Neuroprotective effects of trehalose and sodium butyrate on preformed fibrillar form of α-synuclein-induced rat model of Parkinson’s disease
V Kakoty, S KC, SK Dubey, CH Yang, R Taliyan
ACS Chemical Neuroscience 12 (14), 2643-2660, 2021
232021
Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease
V Kakoty, KC Sarathlal, RD Tang, CH Yang, SK Dubey, R Taliyan
Biomedicine & Pharmacotherapy 127, 110145, 2020
232020
Neuroprotective efficacy of co-encapsulated rosiglitazone and vorinostat nanoparticle on streptozotocin induced mice model of Alzheimer disease
S KC, V Kakoty, KV Krishna, SK Dubey, D Chitkara, R Taliyan
ACS Chemical Neuroscience 12 (9), 1528-1541, 2021
212021
Biological toxicity of nanoparticles
V Kakoty, KC Sarathlal, M Pandey, SK Dubey, P Kesharwani, R Taliyan
Nanoparticle Therapeutics, 603-628, 2022
112022
Brain insulin resistance linked Alzheimer’s and Parkinson’s disease pathology: An undying implication of epigenetic and autophagy modulation
V Kakoty, S Kc, S Kumari, CH Yang, SK Dubey, A Sahebkar, ...
Inflammopharmacology 31 (2), 699-716, 2023
72023
The gut-brain connection in the pathogenicity of Parkinson disease: Putative role of autophagy
V Kakoty, KC Sarathlal, SK Dubey, CH Yang, P Kesharwani, R Taliyan
Neuroscience Letters 753, 135865, 2021
72021
Epigenetic regulation and autophagy modulation debilitates insulin resistance associated Alzheimer’s disease condition in rats
V Kakoty, S KC, SK Dubey, CH Yang, SA Marathe, R Taliyan
Metabolic Brain Disease 37 (4), 927-944, 2022
52022
Lentiviral mediated gene delivery as an effective therapeutic approach for Parkinson disease
V Kakoty, KC Sarathlal, SK Dubey, CH Yang, P Kesharwani, R Taliyan
Neuroscience Letters 750, 135769, 2021
52021
Neuroprotective Effect of Lentivirus-Mediated FGF21 Gene Delivery in Experimental Alzheimer’s Disease is Augmented when Concerted with Rapamycin
V Kakoty, CH Yang, S Kumari, SK Dubey, R Taliyan
Molecular Neurobiology 59 (5), 2659-2677, 2022
32022
Exploring the epigenetic regulated modulation of fibroblast growth factor 21 involvement in high-fat diet associated parkinson’s disease in rats
V Kakoty, S Kc, CH Yang, SK Dubey, R Taliyan
ACS Chemical Neuroscience 14 (4), 725-740, 2023
22023
Fibroblast Growth Factor 21 and Autophagy Modulation Ameliorates Amyloid β‐Induced Alzheimer Disease Pathology in Rats
R Taliyan, V Kakoty, S Kc, S Kumari
Alzheimer's & Dementia 17, e058695, 2021
22021
Epigenetic Regulation of Mammalian Target of Rapamycin Debilitates Insulin Resistance Associated Alzheimer Disease Condition in Rats
V Kakoty, KC Sarathlal, S Dubey, CH Yang, R Taliyan
12021
Unraveling the role of glial cell line–derived neurotrophic factor in the treatment of Parkinson’s disease
V Kakoty, KC Sarathlal, P Kaur, P Wadhwa, S Vishwas, FR Khan, ...
Neurological Sciences, 1-10, 2023
2023
Exploring Applications of Flexible Vesicular Systems as Transdermal Drug Delivery.
P Kaur, S Verma, B Tomar, M Vyas, V Kakoty, P Saha, S Kc
Current Drug Delivery, 2023
2023
Senolytics: opening avenues in drug discovery to find novel therapeutics for Parkinson’s disease
V Kakoty, KC Sarathlal, M Gulati, GB Hing, K Dua, SK Singh
Drug discovery today, 103582, 2023
2023
Development and Validation of PEG‐PCL Based Nanoformulation of Rosiglitazone and Evaluation of its Brain Selectivity in Mice Model of Alzheimer’s disease
S KC, VK Kakoty, R Taliyan
Alzheimer's & Dementia 17, e058674, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–20